Eczema Antihistamines: No Help, More Harm?

A comprehensive review of 47 trials involving over 6,200 individuals with moderate to severe eczema indicates that antihistamines offer minimal clinical benefit and may increase harms. The study, published in the BMJ, found that antihistamines did not significantly reduce eczema severity or itchiness compared to a placebo and did not alleviate sleep disturbance.

First-generation antihistamines, known for causing drowsiness, could also lead to cognitive impairment and treatment discontinuation due to side effects. Researchers assert their findings support evidence-based changes in practice, advocating for updated guidelines that prioritize patient-centered care over routine antihistamine use.

In parallel, innovative vibroacoustic sensor technology developed at Edinburgh's Heriot-Watt University has received over £475,000 in funding for clinical research. This development aims to revolutionize eczema diagnosis and treatment by measuring subsurface tissue changes, potentially alleviating suffering for millions.